Anocca has treated the first patients with TCR-T cell therapy
The therapy ANOC-001 targets the KRAS G12V mutation and is the first TCR-T therapy in Europe using gene-editing technology.
See the latest news and media coverage for Realtid. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish financial news website
realtid.seLast updated
In short: Realtid reported on Nordea facing a massive Danish money laundering fine, Moody's upgrading Handelsbanken, and Sectra's strong financial growth.
The therapy ANOC-001 targets the KRAS G12V mutation and is the first TCR-T therapy in Europe using gene-editing technology.
The meeting approved the accounts, decided on no dividend, re-election of the board and a new incentive program.
Net sales rose to SEK 3,542 million and operating profit to SEK 711 million, with a proposal for increased dividends.
The nomination committee proposes additional remuneration for the audit committee ahead of the 2026 annual general meeting.
The prosecutor in Copenhagen demands 6.6 billion Danish kronor from Nordea for inadequate controls of large transaction flows. Danish authorities have initiated a comprehensive money laundering case against Nordea...
Two weeks into the portfolio battle, the stock market is lower than when bottom fishing began. Realtids portfolio took a hit during the week on a ...
Since Maria Pellborn took over the CEO position at Realtid, the company has increased turnover by 300 percent and halved the loss: "When I came in, there was largely...
In January 2023, Swedish business and finance publication Realtid confirmed that they had reached a settlement with businessman Svante Kumlin over a legal action Kumlin...
Track Realtid and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Realtid and other trending companies.